Picture of IRADIMED logo

IRMD — IRADIMED News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

IRadimed Corp expected to post earnings of 30cents a share - Earnings Preview

* IRadimed Corp  IRMD.OQ   IRMD.O  is expected to show a
rise in
quarterly revenue when it reports  results on February 2. 
    * The Winter Springs Florida-based  company is expected to
report 
a 25.2% increase in revenue to $14.869 million from $11.87
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for IRadimed Corp is
for
earnings of 30 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for IRadimed
Corp is
$45.5​, above​ its last closing price of $36.70. ​​​

This summary was machine generated January 31 at 19:31 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on IRADIMED

See all news